NORGES BANK - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORGES BANK ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$10,533,012
+27.1%
226,419
+41.7%
0.00%
+50.0%
Q3 2022$8,289,812
+25.7%
159,819
+14.6%
0.00%0.0%
Q2 2022$6,594,449
-33.6%
139,5060.0%0.00%0.0%
Q1 2022$9,930,037
+6.8%
139,506
+12.2%
0.00%0.0%
Q4 2021$9,298,000
+48.9%
124,344
+13.1%
0.00%
+100.0%
Q3 2021$6,245,000
+29.1%
109,9360.0%0.00%0.0%
Q2 2021$4,838,000
-23.9%
109,936
-14.7%
0.00%0.0%
Q1 2021$6,358,000
-1.9%
128,914
-16.3%
0.00%
-50.0%
Q4 2020$6,483,000
-11.3%
154,002
-3.6%
0.00%0.0%
Q3 2020$7,311,000
-11.8%
159,694
-3.3%
0.00%0.0%
Q2 2020$8,289,000
-23.7%
165,085
-21.8%
0.00%
-50.0%
Q1 2020$10,859,000
-16.8%
211,1320.0%0.00%0.0%
Q4 2019$13,044,000
+2.8%
211,1320.0%0.00%0.0%
Q3 2019$12,685,000
-24.5%
211,132
+6.0%
0.00%
-20.0%
Q2 2019$16,804,000
-6.6%
199,146
+5.8%
0.01%
-16.7%
Q1 2019$17,987,000
+153.1%
188,301
+87.7%
0.01%
+100.0%
Q4 2018$7,106,000
-4.7%
100,326
+15.0%
0.00%
+50.0%
Q3 2018$7,456,00087,2480.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 564,102$42,184,00014.63%
Fairmount Funds Management LLC 387,400$28,970,0009.55%
Soleus Capital Management, L.P. 318,275$23,801,0002.38%
Darwin Global Management, Ltd. 166,190$12,428,0001.90%
Paradigm Biocapital Advisors LP 75,507$5,646,0001.61%
ARMISTICE CAPITAL, LLC 1,056,000$78,968,0001.29%
KINGDON CAPITAL MANAGEMENT, L.L.C. 150,000$11,217,0001.29%
Portland Global Advisors LLC 75,869$5,673,0000.95%
FARALLON CAPITAL MANAGEMENT LLC 1,573,829$117,691,0000.59%
Yorktown Management & Research Co Inc 10,400$778,0000.52%
View complete list of ENANTA PHARMACEUTICALS INC shareholders